loading
Achieve Life Sciences Inc stock is traded at $2.68, with a volume of 892.59K. It is down -2.55% in the last 24 hours and down -14.65% over the past month. Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
See More
Previous Close:
$2.75
Open:
$2.78
24h Volume:
892.59K
Relative Volume:
1.17
Market Cap:
$92.96M
Revenue:
-
Net Income/Loss:
$-32.94M
P/E Ratio:
-2.4144
EPS:
-1.11
Net Cash Flow:
$-24.95M
1W Performance:
+15.52%
1M Performance:
-14.65%
6M Performance:
-13.27%
1Y Performance:
-43.70%
1-Day Range:
Value
$2.67
$2.82
1-Week Range:
Value
$2.46
$2.85
52-Week Range:
Value
$1.84
$5.31

Achieve Life Sciences Inc Stock (ACHV) Company Profile

Name
Name
Achieve Life Sciences Inc
Name
Phone
425-686-1500
Name
Address
22722 29TH DR. SE, SEATTLE, BC
Name
Employee
25
Name
Twitter
Name
Next Earnings Date
2025-03-11
Name
Latest SEC Filings
Name
ACHV's Discussions on Twitter

Compare ACHV with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ACHV
Achieve Life Sciences Inc
2.68 115.27M 0 -32.94M -24.95M -1.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.81 120.40B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
542.52 61.30B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.53 41.06B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
564.59 34.29B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.55 27.09B 3.81B -644.79M -669.77M -6.24

Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-14-24 Initiated Rodman & Renshaw Buy
Sep-27-24 Initiated Raymond James Strong Buy
May-10-23 Reiterated Maxim Group Buy
Jun-23-21 Initiated Oppenheimer Outperform

Achieve Life Sciences Inc Stock (ACHV) Latest News

pulisher
03:28 AM

What drives Achieve Life Sciences Inc. stock priceHigh-yield trading alerts - PrintWeekIndia

03:28 AM
pulisher
Jul 19, 2025

Is Achieve Life Sciences Inc. a good long term investmentFree Investment Timing Strategies - Jammu Links News

Jul 19, 2025
pulisher
Jul 19, 2025

What analysts say about Achieve Life Sciences Inc. stockOutstanding stock performance - Jammu Links News

Jul 19, 2025
pulisher
Jul 18, 2025

Will Achieve Life Sciences Inc. stock split in the near futureFree Real-Time Market Predictions - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

What makes Achieve Life Sciences Inc. stock price move sharplyFree Discussion Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Achieve Life Sciences Inc. stock attracts strong analyst attentionShort Squeeze Radar - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Achieve Life Sciences Inc. stock performs during market volatilityTop Growth Low Risk Stocks - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Company’s Banking Shares: Up -49.72% from 52-Week Low, But Can the Momentum Hold? - investchronicle.com

Jul 14, 2025
pulisher
Jul 09, 2025

Omnicom, Achieve Life Sciences Partner for AI-Driven Launch of New Nicotine Dependence Treatment - MSN

Jul 09, 2025
pulisher
Jul 07, 2025

Achieve Life Sciences: The AI-Powered Push to Redefine Smoking Cessation - AInvest

Jul 07, 2025
pulisher
Jul 07, 2025

Achieve Life Sciences: Nearing Commercialization Of A Best-In-Class Pharmaceutical Product For Smoking Cessation - Seeking Alpha

Jul 07, 2025
pulisher
Jul 07, 2025

Should You Hold Achieve Life Sciences (ACHV)? - Insider Monkey

Jul 07, 2025
pulisher
Jul 03, 2025

ACHV: Achieve’s Busy Day - Yahoo Finance

Jul 03, 2025
pulisher
Jul 02, 2025

Achieve Life Sciences (ACHV) Receives a Buy from Raymond James - The Globe and Mail

Jul 02, 2025
pulisher
Jul 02, 2025

Achieve Life Sciences stock falls after pricing capital raise of $45M via securities offering - MSN

Jul 02, 2025
pulisher
Jul 01, 2025

CSW INDUSTRIALS EVP, CFO Sell Shares at $284.18/Share on 2025-07-01. - AInvest

Jul 01, 2025
pulisher
Jun 30, 2025

Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters' Option to Purchase Additional Securities | ACHV Stock News - GuruFocus

Jun 30, 2025
pulisher
Jun 30, 2025

Achieve Life Sciences, Inc.(NasdaqCM: ACHV) dropped from Russell 3000 Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Achieve Life Sciences, Inc.(NasdaqCM: ACHV) dropped from Russell 3000 Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Achieve Life Sciences, Inc.(NasdaqCM: ACHV) dropped from Russell 2500 Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Bothell biotech firm plans $45 million public offering to advance smoking cessation drug - The Business Journals

Jun 30, 2025
pulisher
Jun 28, 2025

Tech And Biotech Stocks Take A Dive Following Surprising Announcements - Finimize

Jun 28, 2025
pulisher
Jun 28, 2025

Achieve Life Sciences (NASDAQ:ACHV) Stock Price Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat

Jun 28, 2025
pulisher
Jun 27, 2025

Achieve Life Sciences (ACHV) Submits FDA Application for Smoking Cessation Drug | ACHV Stock News - GuruFocus

Jun 27, 2025
pulisher
Jun 27, 2025

Achieve Life Sciences (ACHV) Stock Plummets Amid Marketing Plans with Omnicom - GuruFocus

Jun 27, 2025
pulisher
Jun 27, 2025

ACHV Gains Attention with Strategic Financial Moves | ACHV Stock News - GuruFocus

Jun 27, 2025
pulisher
Jun 27, 2025

Achieve Life Sciences (ACHV) Launches $45 Million Stock Offering - GuruFocus

Jun 27, 2025
pulisher
Jun 27, 2025

Achieve Life Sciences names Omnicom as strategic partner for launch By Investing.com - Investing.com India

Jun 27, 2025
pulisher
Jun 27, 2025

Achieve Life Sciences Announces Pricing of $45.0 Million Underwr - GuruFocus

Jun 27, 2025
pulisher
Jun 26, 2025

Achieve Life Sciences announces proposed public offering; shares down nearly 13% - MSN

Jun 26, 2025
pulisher
Jun 26, 2025

Achieve Life Sciences announces public offering to fund cytisinicline By Investing.com - Investing.com Canada

Jun 26, 2025
pulisher
Jun 26, 2025

Achieve Life Sciences Announces Submission of NDA to FDA - GlobeNewswire

Jun 26, 2025
pulisher
Jun 26, 2025

Breakthrough Smoking Cessation Drug Could Help 29M Americans: FDA Review Begins - Stock Titan

Jun 26, 2025
pulisher
Jun 23, 2025

Achieve adds vapers to smokers in targeting multi-billion dollar market - The Pharma Letter

Jun 23, 2025
pulisher
Jun 17, 2025

Bank of America Corp DE Purchases 9,760 Shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World

Jun 17, 2025
pulisher
Jun 15, 2025

Institutional investors may adopt severe steps after Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) latest 15% drop adds to a year losses - simplywall.st

Jun 15, 2025
pulisher
Jun 12, 2025

Owning 46% shares,institutional owners seem interested in Achieve Life Sciences, Inc. (NASDAQ:ACHV), - Yahoo

Jun 12, 2025
pulisher
Jun 11, 2025

Squarepoint Ops LLC Buys Shares of 17,519 Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World

Jun 11, 2025
pulisher
Jun 07, 2025

achieve life sciences holds annual meeting with key votes By Investing.com - Investing.com India

Jun 07, 2025
pulisher
Jun 06, 2025

Achieve Life Sciences Elects Board at Annual Meeting - TipRanks

Jun 06, 2025
pulisher
Jun 06, 2025

achieve life sciences holds annual meeting with key votes - Investing.com

Jun 06, 2025
pulisher
Jun 05, 2025

Achieve Life Sciences (NASDAQ:ACHV) Shares Pass Above 200 Day Moving Average – What’s Next? - Defense World

Jun 05, 2025
pulisher
Jun 03, 2025

Achieve Life Sciences: FDA Approval Not Assured, But Valuation Justifies Risk (ACHV) - Seeking Alpha

Jun 03, 2025
pulisher
May 28, 2025

Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference - GlobeNewswire

May 28, 2025

Achieve Life Sciences Inc Stock (ACHV) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Achieve Life Sciences Inc Stock (ACHV) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Stewart Richard Alistair
Chieve Executive Officer
Mar 17 '25
Buy
2.86
10,000
28,598
60,876
$21.88
price down icon 0.59%
$35.59
price up icon 0.34%
$102.56
price down icon 1.55%
$26.20
price down icon 5.18%
$110.02
price down icon 0.92%
biotechnology ONC
$294.55
price up icon 1.45%
Cap:     |  Volume (24h):